Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors.
Future Oncol
; 19(26): 1801-1807, 2023 Aug.
Article
en En
| MEDLINE
| ID: mdl-37737023
This paper summarizes the findings from 48 clinical trials conducted since the 1970s about the treatment of leptomeningeal metastases through an intrathecal approach (administering drugs directly into the cerebrospinal fluid a fluid that surrounds the brain and spinal cord). The results of these studies suggest that although these therapies show promise for the future, they currently do not clearly and consistently report a benefit. Further work is needed to explore the possible use of these treatments.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Líquido Cefalorraquídeo
/
Neoplasias Meníngeas
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Future Oncol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Reino Unido